Caplacizumab Alternatives Compared
| Caplacizumab | Cablivi (caplacizumab) | Adzynma (apadamtase alfa, recombinant) |
|
|---|
| Caplacizumab | Cablivi (caplacizumab) | Adzynma (apadamtase alfa, recombinant) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Thrombotic Thrombocytopenic Purpura. Caplacizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Thrombotic Thrombocytopenic Purpura. Cablivi may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Thrombotic Thrombocytopenic Purpura. Adzynma may also be used for purposes not listed in this medication guide. |
Related suggestions Thrombotic Thrombocytopenic Purpura
|
|||||||||||||||
| More about Caplacizumab | More about Cablivi (caplacizumab) | More about Adzynma (apadamtase alfa, recombinant) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Adzynma has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Caplacizumab side effects |
View all Cablivi side effects |
View all Adzynma side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Cablivi prices |
View all Adzynma prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Cablivi |
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
N/A |
47.8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 161 drugs are known to interact with Caplacizumab:
|
A total of 161 drugs are known to interact with Cablivi:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
February 06, 2019 |
February 06, 2019 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Adzynma
Adzynma (ADAMTS13, recombinant-krhn) is a human recombinant protein that may be used to prevent or ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Aggrenox
Aggrenox (aspirin and dipyridamole) is used to reduce the risk of stroke in people who have had ...
Arthritis Pain
Arthritis Pain is used for angina, angina pectoris prophylaxis, ankylosing spondylitis ...
Ascriptin
Ascriptin is used for angina, angina pectoris prophylaxis, antiphospholipid syndrome, back pain ...
Aspergum
Aspergum is used for angina, angina pectoris prophylaxis, ankylosing spondylitis, antiphospholipid ...
Aspir-Low
Aspir-Low is used for angina, angina pectoris prophylaxis, heart attack, ischemic stroke, ischemic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.